tiprankstipranks
Cogent Biosciences (COGT)
NASDAQ:COGT
US Market

Cogent Biosciences (COGT) Income Statement

Compare
558 Followers

Cogent Biosciences Income Statement

Last quarter (Q4 2024), Cogent Biosciences's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Cogent Biosciences's net income was $-67.93M. See Cogent Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 7.87M
Gross Profit
$ 0.00$ -3.59M$ -5.88M$ -147.00K$ 7.85M
Operating Expenses
$ 275.94M$ 208.13M$ 147.84M$ 75.55M$ 90.07M
Depreciation and Amortization
$ 0.00$ 2.27M$ 5.88M$ 147.00K$ 720.00K
EBITDA
$ -275.94M$ -205.86M$ -134.36M$ -75.40M$ -34.57M
Operating Income
$ -275.94M$ -208.13M$ -147.84M$ -75.55M$ -82.20M
Other Income/Expenses
$ 20.08M$ 15.72M$ 7.60M$ 3.28M$ 7.39M
Pretax Income
$ -255.86M$ -192.41M$ -140.24M$ -72.27M$ -74.81M
Net Income
$ -255.86M$ -192.41M$ -132.64M$ -71.81M$ -66.45M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.49$ -2.42$ -2.26$ -1.85$ -6.00
Diluted EPS
$ -3.49$ -2.42$ -2.26$ -1.85$ -6.00
Weighted Average Shares Outstanding
73.35M 79.66M 58.74M 38.73M 11.08M
Weighted Average Shares Outstanding (Diluted)
73.35M 79.66M 58.74M 38.73M 11.08M
Currency in USD

Cogent Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis